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ABSTRACT 
Out of 906 cultures isolates, 263 (29.0%) were confirmed as NTM and 724 (71.0%) were identified as Mycobacterium tuberculosis complex. The 
diversity of NTM species was high and predominated by Mycobacterium abscessus (31.3%) followed by M. fortuitum (22%), M. 
intracellulare (13.6%), M. chelonae (9.1%), however, M. abscessus and M. fortuitum were the predominant species in both types of clinical 
isolates. Men (60.4%) and older patients aged greater than 55 years were the predominated risk group for NTM infection. Additionally, three 
HIV/AIDS cases (1.1%), as well as thirty five cases were found to be type two diabetes mellitus infected with non-tuberculous bacteria. 
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Non-tuberculous mycobacteria (NTM) infection associated 
with pulmonary and extra-pulmonary disease has been 
increasing globally. In many countries, NTM infections have 
become more common than M. tuberculosis (MTB). NTM is 
ubiquitous in nature and everyone is exposed with them; 
however only a little people can get a NTM infection. Despite 
an increase in incidence rate of NTM infection, its 
prevalence, species diversity, and antibiotic susceptibility 
pattern in India is largely unknown1-4.  
Occurrence of NTM has been reported in human respiratory 
and non respiratory diseases. A continuous global rise in 
NTM incidence is a big concern for physicians and 
microbiologists. Earlier in various developing countries, the   
higher   occurrence of tuberculosis has   surpassed   the 
identification of NTM associated infections5-8. Most of these 
are present mainly in the form of saprophytes in the natural 
surrounding and have been identified as an etiological agent 
in human diseases. Now days this trend is changing with 
great pace. Higher reporting of NTM related pulmonary 
disease leads to international attention6-10. As of, 2014 
estimated incidence of respiratory disease was 33–65 per 
100,000 due to NTM11-14. 
However, culture of mycobacteria and detection of NTM are 
not regularly done in many regions of India. NTM infection 
prevalence in India still unclear. Therefore, in high burden 
resource areas; there is immediate requirement for the 
routine detection of NTM infected individuals. Since  the   
recent   standard   of  care does   not   include the  
characterization of bacteria ,in  some  positive  NTM  cases , 
is classified  incorrectly as MTBC  and  receives  conventional  
TB  therapy, however some  species of NTM  can be resistant  
against treatment and  many of them  are unable to diagnose.  
Restricted information  on  the occurrence of NTM and 
genotypic characterization among  patients  is available  in  
India and  infections  of NTM are  not  well  documented. In 
present study, we investigate; compare different 
identification techniques for detection of mycobacterium 
species in clinical samples15-18. 
MATERIALS AND METHODS 
Study Design and Study Setting 
This study designed as a prospective hospital based study in 
Northern India at department of Microbiology, Sanjay 
Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 
UP India. 
Sample Sites 
 Pulmonary sites (Sputum, bronchoalveolar lavage) and extra 
pulmonary sites (Body fluids, pus and tissues, CSF, lymph 
node aspirates, pleural fluid, pus, bone marrow aspirates, 
peritoneal fluid, ascitic fluid, synovial fluid, and other body 
fluids) was collected from clinically assumed cases of 
tuberculosis.  
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Inclusion Criteria  
 Clinically suspected of tuberculosis including pulmonary 
TB and extra-pulmonary TB was  included 
 Culture positives for mycobacteria was  included  
 HIV and other immune-compromised patients 
suspected of TB was  included  
 All  age groups and sex supposed of having  included  
 NTM confirmed strains  included  
Exclusion Criteria 
 MTBC excluded. 
 Culture negative specimens excluded. 
 Those patients not willing participates in this study 
were excluded. 
Processing of Specimens 
The processing of sample was divided in two parts: non 
sterile specimens (Sputum, bal fluid, wound swabs, pus, 
discharging fluids etc.), which includes bacterial normal 
commensal flora, were processed and decontaminated by 
standard N-acetyl-L-cysteine-NaOH (NALC-NaOH) process. It 
was centrifuged and sediment separated into two half, one 
half was utilized for AFB microscopy and another is used for 
culture. Sterile sites specimens (Synovial, ascetic fluid, 
pericardial fluid, CSF, pleural fluid, etc) were centrifuged and 
sediment divided into two half, one half was utilized for AFB 
microscopy and other is culture in BACT/ALERT 3D Culture.   
Different technique for identification of NTM using 
biochemical test 
Biochemical test commonly was done for identification of the 
commonly encountered NTM species. The following test was 
carried out arylsulfatase, iron uptake, nitrate reductase, 
catalase, urease, Tween80, tolerance to 5% NaCl, and 
utilization of the carbohydrates mannitol, inositol, and 
citrate and Mac-Conkey agar absence of crystal violet as 
described. 
SD- Bioline Assay 
A  100  μl  supernatant  of  sample  from  liquid  culture  was  
put into the  sample well. From solid culture used few 
colonies mix into buffer and the suspension was added into 




A ;  Positive Band ( M.tuberculosis complex)
B;    Negative   (NTM)
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Control Band (C)
 
Figure 1: differentiation of NTM and MTBC by bio-line SD 
AG MPT64 antigen test 
Band of Pink color in the 'C' region of control confirmed as a 
test is valid. The pink band in the 'T' region test line and 'C' 
region was control line reported as positive for MPT64 
antigen test. Only pink band in the 'C' region and band not 
present in the 'T' region were regarded as negative for MPT 
64 antigen. There have no bands in 'C' region was considered 
as invalid test. Both test line and control line is present is 
called as MTBC and in control line is present interpretate as 
MOTT (Figure 1). 
Genotype® Mycobacterium CM/AS Assay  
The detection of NTM and differentiation (RGM and SGM) 
species was completed by the GenoType® Mycobacterium 
CM/AS assay of BacT/ALERT® MP positive culture isolates of 
mycobacteria.  
Dna Extraction  
Extraction of DNA was subjected for 15 minutes using 
sonication method, followed by heating for 15 min to 100⁰C. 
Positive culture broth was centrifuged at 13, 400 g for 2 
minutes and the supernatant was further used for the PCR.  
PCR  
PCR was carried out using specific primers set designed to 
amplify a species specific 23S rRNA gene sequence of 
mycobacterium species. Amplification mixture (45µl) was 
made in DNA free area, containing 5 µl extracted DNA (20-
100 ng DNA) in reaction mixture included 35 µl PNM, 5 µl 
10X polymerase incubation buffer, MgCl2 solution 2 µl 25 
mM, HotStar Taq 0.2 µl (QIAGEN, Hilden, Germany) and 3 
water µl (biology grade water) and after that used 0.5 µl 
extracted DNA. Finally vortex the tubes and subjected to 
PCR. Amplification was completed in a thermal cycler (Gene 
Amp PCR System 9700 Thermal Cycler), which involved 01 
cycles is denaturation for 15 at 95°C minutes, then annealing 
of primers for 30 seconds at 95°C, 2 minutes at 58°C for 10 
cycles, then at 95°C for 25 seconds of 20 cycles, 53°C for 40 
seconds, and 70°C for 40 seconds, and final extension of 
primer at 70°C, 8 minute for 01 cycle. And then amplified 
PCR results were stored at +8 to -20°C till hybridization was 
not performed in machine of hybridization (Profiblot; Tekan, 
Maennedorf, Switzerland). 
PCR reaction mixture 







PNM 35 µl  
PCR water 5 µl 10X 
MgCl2 solution, 2 µl 25 mM 
HotStar Taq 0.2 µl  
biology grade water 3 µl  
DNA 0.5 µl  
 
Reverse Hybridization 
Further after the amplification this was followed by 
hybridization (Profiblot; Tekan, Maennedorf, Switzerland). ; 
in which denaturation solution (DEN, blue) 20 µl of was 
distributed in corner of every well, and then 20 µl of product 
amplified PCR was dispensed  and incubated at room 
temperature for 5 minutes. Then pre-heated 1 ml of 
hybridization buffer (HYB, Green) was dispensed, after that 
shake gently until a homogenous color was appeared. Then 
strip was placed in a systematic way to make sure whole 
flooding of solution above on the strips. After that the tray 
was put in TwinCubator and was incubated at 45⁰C for 30 
minutes, then total aspiration of hybridization buffer. 
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Washing requires 1 ml of stringent wash solution to every 
strip and incubated at 45⁰C for 15 minutes in TwinCubator. 
Further washing of strips was done with 1 ml of rinse 
solution on TwinCubator for 1 minute. After that each strips 
were diluted 1 ml conjugate solution and incubated for 30 
minutes on TwinCubator. Again Strips were washed with 1 
ml of rinse solution for 1 minute, followed by addition of 1 
ml of diluted substrate to each strips and incubated in 
absence of light without shaking for 3-20 minutes. To stop 
this reaction rinsing was carried out twice with distilled 
water. At the end, strips were taken out and dried between 
two layers of blotting paper. Evaluation and interpretation of 
results were done based on the presence and absence of 
different bands and compared with reference band as 
provided in the kit given as; 
The developed strips were pasted in the selected fields by 
line up the universal control (UC) and conjugate control (CC) 
and genus control (GC) bands with the particular lines on the 
evaluation page. 
The Conjugate control (CC); this band must develop to 
confirm the effectiveness of the conjugate binding and the 
substrate reaction. 
The universal control (UC) band detect all known 
Mycobacterium species and constituent of the faction of 
Gram positive bacteria with high G+C content. If the bands 
conjugate control, the universal control band and other 
bands are positive but pattern that cannot be allocate to 
exact Mycobacterium species. Merely those bands whose 
strength is about as strong as or stronger than that of the 
universal control are to be considered. 
The genus control (G-C) band confirms the organism is a 
constituent of the Mycobacterium genus, the intensity of the 
band varies depending on the Mycobacterium species. 
Results interpretation was complete according to the 
absence and presence of bands compared with reference 
provided in the kit. The organisms were recognized based on 
the position and number of bands formed on the strip 
(Figure 2). 
Data Analysis 
The clinical and demographic data were analyzed by using 
SPSS version 19.0 (IBM, NY, USA) software package. 
Genotype CM/AS assay results were interpreted based on 
manufacturers protocol. 
 
Figure 2: Discrimination of different species of 
mycobacteria strains no 17, 7, and 1 was identified as 
NTM and 5, 8 AS MTBC using Genotype® CM/AS assay.  
RESULTS  
Differentiation of MTBC and NTM  
Primary screening of culture positive isolates i.e., (906 cases) 
were done by colony morphology using different 
biochemical tests such as catalase test, nitrate reduction and 
niacin production, which identified 651 (71.9%) MTBC and 
255 (28.1%) NTM. Further, another technique Rapid 
BIO-LINE SD Ag MPT64 TB was carried out on total positive 
isolates of mycobacteria irrespective of their day of culture 
positivity. Out of Nine Hundred Six culture positive isolates, 
641 isolates confirms the subsistence of MPT 64 antigen 
appearance and thus shows presence of MTBC while  
remaining 265 isolates were identified as NTM (Table ). A 
confirmatory (gold standard) test was carried out using 
GenoType® Mycobacterium CM/AS assay which confirmed 
643 (70.9%) isolates, showed presence of distinct band at 
position 10 and 16 which reflected a positive test for MTBC 
while other band patterns confirmed 263 (29.1%) different 
species of NTM (Table 1). 
  
Table 1: Distribution of mycobacterial isolates according to the identification test performed. 
Biochemical test MPT 64 Ag test Genotypic CM/AS Assay 
Positive Negative Positive Negative MTBC NTM 
651(71.8%) 255 (28.1%) 641(70.7%) 265(29.2%) 643(70.9%) 263(29%) 
  
Specificity and sensitivity of different techniques 
Among different diagnostic tests applied for specificity, 
sensitivity, negative (NPV) and positive predictive value 
(PPV), GenoType® Mycobacterium CM/AS assay which is  
gold standard method  shows highest specificity and 
sensitivity as compared to MPT64 Ag test and other 
biochemical test respectively (Table 2). From this study, it 
can be concluded that molecular test are more sensitive and 
specific for the identification of NTM and MTBC in given 
samples.  
 
Table 2: sensitivity and specificity of MPT64 AG test and 
biochemical test in comparison to genotype® 
mycobacterium CM/AS assay for discrimination between 





Sensitivity 99.68% 98.78% 
Specificity 99.24% 96.95% 
PPV 99.68% 98.78% 
NPV 99.24% 96.95% 
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DISCUSSION AND CONCLUSION 
Smear microscopy for AFB is rapid, on the other hand does 
not distinguish between NTM and MTBC. Phenotypic 
techniques such as staining of a growth and a group of 
various biochemical methods are not able to differentiate 
more than 100 species of Mycobacteria, as they overlap in 
their biochemical properties. Two isolates were correctly 
detected as MTBC by LPA were falsely diagnosed as NTM by 
using MPT 64 test. In earlier studies , it is reported that 
MPT64 BIO‑ LINE SD Ag kit sensitivity of  90‑ 100% for 
differentiation of NTM and MTBC species. In this study we 
have identified that the 99.4% sensitivity for MTBC isolates 
by BIO‑ LINE SD MPT64 Ag. Many other studies that 
compared the GenoType® Mycobacterium CM/AS technique 
with various genotypic and phenotypic tests and reported 
outstanding outcomes .The benefit of using this assay is 
quick and correct detection of a wide range of Mycobacterial 
species the same as evaluate with molecular techniques and 
phenotypic, which fails to distinguish various species of NTM 
accurately. The additional uses of this are very less time as 
compared with conventional tests and molecular methods.  
In this research we have found higher prevalence of NTM 
from both site clinical specimens. Rapid growing species 
M.abscessus and M.fortuitum are most recurrently isolated 
and slow growers M.intermedium and M.malmoense are least 
isolated in our study. The risk factors that were found to be 
related with infections of NTM gender, age groups 
respiratory symptoms presence and HIV infection. Molecular 
methods are an indispensible tool as it diminishes the 
possibility of an inadequate treatment of infection related to 
NTM. This may gradually replace conventional techniques 
for the identification and discrimination of NTM. The higher 
occurrence of NTM and its species diversity suggests the 
urgent need and exact characterization including antibiotic 
susceptibility connected with NTM required for appropriate 
management and treatment of patients. 
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